# US 2023/0227865 A1 · Modified Microorganisms and Production Method of Compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0227865 A1
- Document ID: US20230227865A1
- Status: Published application
- Kind: A1
- Application number: 18/152,907
- Filed: 2023-01-11
- Published: 2023-07-20
- Earliest claimed: 2022-01-19
- Assignees: Asahi Kasei Kabushiki Kaisha
- Applicants: Asahi Kasei Kabushiki Kaisha
- Inventors: Yutaro Yamada; Ryo Miyatake; Koji Isaka
- Web page: https://patentgrep.com/patent/US20230227865A1

## CPC

- C12P 7/44: Polycarboxylic acids
- C07K 14/245: Escherichia (G)
- C12N 9/0006: {acting on CH-OH groups as donors (1.1)}
- C12N 9/0008: {acting on the aldehyde or oxo group of donors (1.2)}
- C12N 9/1029: {transferring groups other than amino-acyl groups (2.3.1)}
- C12N 9/88: Lyases (4.)
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12P 7/18: polyhydric
- C12P 7/42: Hydroxy-carboxylic acids
- C12P 13/001: {Amines; Imines}
- C12P 13/005: {Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids}
- C12P 13/02: Amides, e.g. chloramphenicol {or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes (peptides C12P21/00 or C07K)}
- C12Y 102/04001: Pyruvate dehydrogenase (acetyl-transferring) (1.2.4.1)
- C12R 2001/19: Escherichia coli
- C12Y 101/01035: 3-Hydroxyacyl-CoA dehydrogenase (1.1.1.35)
- C12Y 203/01174: 3-Oxoadipyl-CoA thiolase (2.3.1.174)
- C12Y 402/01017: Enoyl-CoA hydratase (4.2.1.17), i.e. crotonase
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

A modified microorganism containing a genetic modification that suppresses a transcription factor that controls expression of pyruvate dehydrogenase, in which the microorganism has and a production pathway of a C6 compound, and in which the C6 compound is at least one compound selected from the group consisting of adipic acid, hexamethylenediamine, 1,6-hexanediol, 6-aminohexanoic acid, 6-amino-1-hexanol, 6-hydroxyhexanoic acid, 3-oxoadipic acid, 3-hydroxyadipic acid, and 2,3-dehydroadipic acid.

## Claims

### Claim 1

A modified microorganism comprising a genetic modification that suppresses a transcription factor that controls expression of pyruvate dehydrogenase,
wherein the microorganism has a production pathway of a C6 compound, and
wherein the C6 compound is at least one compound selected from the group consisting of adipic acid, hexamethylenediamine, 1,6-hexanediol, 6-aminohexanoic acid, 6-amino-1-hexanol, 6-hydroxyhexanoic acid, 3-oxoadipic acid, 3-hydroxyadipic acid, and 2,3-dehydroadipic acid.

### Claim 2 (depends on 1)

The modified microorganism according to claim 1, wherein the genetic modification that suppresses a transcription factor that controls expression of pyruvate dehydrogenase is one or more selected from:
a modification that suppresses expression of a gene encoding the transcription factor. and
a modification that reduces an activity of the transcription factor in comparison to a non-reduced strain.

### Claim 3 (depends on 1)

The modified microorganism according to claim 1, wherein the modified microorganism belongs to a genus selected from the group consisting of Escherichia, Bacillus, Corynebacterium, Arthrobacter, Brevibacterium, Clostridium, Zymomonas, Pseudomonas, Burkholderia, Streptomyces, Rhodococcus, Synechocystis, Alkalihalobacillus, Saccharomyces, Schizosaccharomyces, Yarrowia, Candida, Pichia, and Aspergillus.

### Claim 4 (depends on 1)

The modified microorganism according to claim 1 wherein the modified microorganism is Escherichia coli.

### Claim 5 (depends on 1)

The modified microorganism according to claim 1 wherein the transcription factor that controls expression of pyruvate dehydrogenase is PdhR.

### Claim 6 (depends on 1)

A method for producing a C6 compound, the method comprising a culture step of culturing the modified microorganism according to claim 1.
